Canaccord Genuity Group Reiterates Buy Rating for Netcall (LON:NET)

Netcall (LON:NET)‘s stock had its “buy” rating reissued by analysts at Canaccord Genuity Group in a note issued to investors on Wednesday,Digital Look reports. They presently have a GBX 160 target price on the stock. Canaccord Genuity Group’s price objective would suggest a potential upside of 56.86% from the company’s previous close.

Separately, Berenberg Bank restated a “buy” rating and set a GBX 165 price objective on shares of Netcall in a research note on Wednesday. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of GBX 162.50.

Netcall Stock Performance

NET traded down GBX 1 on Wednesday, reaching GBX 102. 393,725 shares of the stock were exchanged, compared to its average volume of 387,212. The company has a debt-to-equity ratio of 2.37, a current ratio of 0.86 and a quick ratio of 0.88. The company’s 50-day moving average price is GBX 119.01 and its 200 day moving average price is GBX 117.98. The firm has a market capitalization of £173.89 million, a PE ratio of 42.32 and a beta of 0.23. Netcall has a fifty-two week low of GBX 88 and a fifty-two week high of GBX 138.

Netcall (LON:NET) last announced its quarterly earnings data on Wednesday, March 4th. The company reported GBX 2.43 earnings per share for the quarter. Netcall had a return on equity of 9.39% and a net margin of 8.44%. As a group, sell-side analysts forecast that Netcall will post 3.7029017 EPS for the current fiscal year.

Netcall Company Profile

Netcall is a UK-based enterprise software company that unites automation and customer engagement in one AI-powered platform. Its Liberty platform makes work easier by digitising processes and simplifying customer interactions in a single, easy-to-use solution that reduces complexity. Today, around 600 organisations across healthcare, government and financial services rely on Netcall for mission‑critical workflows, including two‑thirds of NHS Acute Health Trusts and major enterprises such as Legal & General, Baloise and Santander.